Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats

Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats

Doxorubicin (DOX) is a cytotoxic anthracycline antibiotic and one of the important chemotherapeutic agents for different types of cancers. DOX treatment is associated with adverse effects, particularly cardiac dysfunction. This study examined the cardioprotective effects of carvedilol (CAR) and/or r...

Full description

Bibliographic Details
Main Authors: Abeer M. Alanazi, Laila Fadda, Ahlam Alhusaini, Rehab Ahmad, Iman H. Hasan, Ayman M. Mahmoud
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Antioxidants
Subjects:
doxorubicin
s100a1
carvedilol
phenols
oxidative stress
cardiomyopathy
Online Access:https://www.mdpi.com/2076-3921/9/2/159

Similar Items

Similar Items